Nutrición trófica en pacientes sometidos a oxigenoterapia de alto flujo y/o ventilación mecánica no invasiva

Observational study for the improvement of a digital health platform for remote monitoring of patients with heart failure.

Observational study to assess the absolute BuRden Of hpv-relate heAd nEck caNcers, The BROADEN study.

Open-Label, Global, Multicenter, Randomized, Phase 3 Study of Sacituzumab Govitecan Versus Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum- Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

Open-label, Multi-centre, Non-Inferiority study of safety and immunogenicity of BIMERVAX® as heterologous booster for the prevention of coronavirus disease 2019 (COVID-19) in adolescents from 12 years to less than 18 years of age

Opicapona y Perfiles de TratamIento en consultas de Trastornos del MOvimiento

Optimizar la detección de fibrilación atrial en el ataque isquémico transitorio

Outcomes of elective cancer surgery during the COVID-19 pandemic crisis: an international, multicentre, observational cohort study.

Outcomes of the spanish cohort of early access to pertuzumab and trastuzumab emtansine

Paper del bloqueig del múscul quadrat lumbar bilateral ecoguiat com a tècnica analgèsica en el dolor agut postoperatori en la cirurgia d’hemorroides i en el dolor crònic pèlvic perineal crònic

Percepció del paciente oncohematològico i cuidador principal del risc de caigudes. MÀSTER ICO BADALONA

Percepció dels pares sobre el mètode cangur realitzat a la UCI Neonatal.

Percepción del grado de seguridad de los pacientes hospitalizados en un hospital de la provincia de Girona de nivel 2B.

PeriOperative ISchemic Evaluation-3 (POISE-3) Trial. Ensayo Clínico que Evalúa la Isquemia Perioperatoria

Phase 3 Trial of Fianlimab (Regn3767, Anti-Lag-3) + Cemiplimab versus Pembrolizumab in patients with previously untreated unresectable locally advanced or metastatic Melanoma

Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF 302)

Phase 3, Randomized, Open-Label Study to Compare Ociperlimab (BGB-A1217) Plus Tislelizumab (BGB-A317) Plus Concurrent Chemoradiotherapy (cCRT) Followed by Ociperlimab Plus Tislelizumab or Tislelizumab Plus cCRT Followed by Tislelizumab Versus cCRT Followed by Durvalumab in Previously Untreated, Locally Advanced, Unresectable Non-Small Cell Lung Cancer

Phase Ib/II Multicentric Study Combining Glasdegib (PF-04449913) with temozolomide in patients with newly diagnosed Glioblastoma, safety and preliminary efficacy for the combination.

Phase II multicenter randomized trial to assess the efficacy and safety of first line nivolumab in combination with paclitaxel in subjects with R/M HNSCC unable for cisplatin-based chemotherapy

PHASE II RANDOMIZED, CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ABTL0812 IN COMBINATION WITH FOLFIRINOX FOR FIRST-LINE TREATMENT OF METASTATIC PANCREATIC CANCER